Interventional Cardiology & Surgery
News
FDA Panel Questions Intracranial Stent Approval
Conference Coverage
Renal Denervation Outcomes for Resistant Hypertension Persist at 3 Years
Major Finding: At baseline the 153 participants had a mean office blood pressure of 175/98 mm Hg despite being on an average of 5.1...
Commentary
Preventing Atherothrombotic Events? It's Complicated
News
Point-of-Care Test Opens Door to Tailored Antiplatelet Therapy
Major Finding: Compared with CYP2C19*2 carriers who received standard treatment (clopidogrel), those who received treatment tailored to their...
Conference Coverage
CABG Survival Beats PCI in Big U.S. Dataset
Major Finding: Adjusted mortality in U.S.
Conference Coverage
Paravalvular Regurgitation Shown Major TAVR Limitation
Major Finding: Two years after intervention, 48% of TAVR patients had trace or no paravalvular aortic regurgitation vs.
News
CORONARY Trial Fails to Show Superiority of Off-Pump CABG
News
Cilostazol Matches Double-Dose Clopidogrel Following PCI
Major Finding: Treatment with cilostazol, clopidogrel, and aspirin was noninferior to double-dose clopidogrel and aspirin during 30 days after...
News
Intracoronary Abciximab Reduces Size of Large Myocardial Infarcts
Major Finding: Median infarct size at 30 days, as measured by cardiac MRI, was 15.1% in patients who received intracoronary abciximab in...
News
Elective Angioplasty Safe at Hospitals Without Surgical Backup
Major Finding: Mortality at 6 weeks was 0.9% at hospitals without on-site surgery, compared with 1% at those with on-site surgery, meeting the...
Video
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders
Major Finding: High platelet reactivity in nonresponders to standard-dose clopidogrel was documented in 28% of patients on double-dose clopidogrel...